Eiko Lifesciences Ltd vs Ghcl Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 18, 2026

Key Highlights

The Latest Trading Price of Eiko Lifesciences Ltd is ₹ 53.65 as of 18 Mar 15:30 . The P/E Ratio of Eiko Lifesciences Ltd changed from 31.1 on March 2025 to 31.1 on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of GHCL Ltd changed from 6.7 on March 2021 to 9.4 on March 2025 . This represents a CAGR of 7.01% over 5 years The Market Cap of Eiko Lifesciences Ltd changed from ₹ 65.15 crore on March 2025 to ₹ 65.15 crore on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe Market Cap of GHCL Ltd changed from ₹ 2187 crore on March 2021 to ₹ 5880 crore on March 2025 . This represents a CAGR of 21.87% over 5 years The revenue of Eiko Lifesciences Ltd for the Dec '25 is ₹ 12.33 crore as compare to the Sep '25 revenue of ₹ 11.97 crore. This represent the growth of 3.01% The revenue of GHCL Ltd for the Dec '25 is ₹ 772.67 crore as compare to the Sep '25 revenue of ₹ 738.32 crore. This represent the growth of 4.65% The ebitda of Eiko Lifesciences Ltd for the Dec '25 is ₹ 2.22 crore as compare to the Sep '25 ebitda of ₹ 2.07 crore. This represent the growth of 7.25% The ebitda of GHCL Ltd for the Dec '25 is ₹ 174.8 crore as compare to the Sep '25 ebitda of ₹ 174.27 crore. This represent the growth of 0.3% The net profit of Eiko Lifesciences Ltd changed from ₹ 0.35 crore to ₹ 1.43 crore over 7 quarters. This represents a CAGR of 123.51% The net profit of GHCL Ltd changed from ₹ 150.63 crore to ₹ 106.01 crore over 7 quarters. This represents a CAGR of -18.19% The Dividend Payout of Eiko Lifesciences Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of GHCL Ltd changed from 16.86 % on March 2021 to 18.35 % on March 2025 . This represents a CAGR of 1.71% over 5 years .

About Eiko Lifesciences Ltd

Eiko Lifesciences Limited was originally incorporated on January 07, 1977, under the name Narendra Investments (Delhi) Limited.
Later, the Company changed its name from Narendra Investments (Delhi) Limited to Eiko LifeSciences Limited effective from June 24, 2021.
Earlier, the Company engaged in sale and purchase of shares and securities.
At present, the Company is a leading manufacturer, supplier and exporter of Speciality Chemicals and Pharma Intermediates in India and globally. The Company commenced new business activity primarily in manufacturing of speciality and fine chemicals in October, 2020 from manufacturing facility located at Badlapur, Maharashtra and has since scaled its operations, grown brand and customer base to become the one of the fastest growing speciality chemicals companies in India.

About GHCL Ltd

GHCL Limited was formerly incorporated as 'Gujarat Heavy Chemicals Limited' on October 14, 1983 in the joint sector by the GIIC and the Dalmias, through their companies - GTC Industries and Dalmia Dairy Corporation.
The Company later on changed the name from ''Gujarat Heavy Chemicals Limited' to 'GHCL Limited' on November 21, 2003.
The Company is among one of India's leading manufacturers of Soda Ash (Anhydrous Sodium Carbonate).
It manufacture 60,000 MTPA of refined Sodium bicarbonate or Baking Soda, which is marketed under brand name - LION. It finds application as a food additive, animal nutritive, plating and dyeing agent.
It has captive limestone mines at Sutrapada, Veraval and Talala Taluka in Gujarat.

FAQs for the comparison of Eiko Lifesciences Ltd and GHCL Ltd

Which company has a larger market capitalization, Eiko Lifesciences Ltd or GHCL Ltd?

Market cap of Eiko Lifesciences Ltd is 76 Cr while Market cap of GHCL Ltd is 4,150 Cr

What are the key factors driving the stock performance of Eiko Lifesciences Ltd and GHCL Ltd?

The stock performance of Eiko Lifesciences Ltd and GHCL Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Eiko Lifesciences Ltd and GHCL Ltd?

As of March 18, 2026, the Eiko Lifesciences Ltd stock price is INR ₹53.65. On the other hand, GHCL Ltd stock price is INR ₹451.5.

How do dividend payouts of Eiko Lifesciences Ltd and GHCL Ltd compare?

To compare the dividend payouts of Eiko Lifesciences Ltd and GHCL Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.